Healthcare costs and resource utilization of asthma in Germany: a claims data analysis

Jacob C, Bechtel B, Engel S, Kardos P, Linder R, Braun S, Greiner W (2016)
EUROPEAN JOURNAL OF HEALTH ECONOMICS 17(2): 195-201.

Download
Es wurde kein Volltext hochgeladen. Nur Publikationsnachweis!
Zeitschriftenaufsatz | Veröffentlicht | Englisch
Autor
; ; ; ; ; ;
Abstract / Bemerkung
Introduction Asthma is associated with a substantial economic burden on the German Statutory Health Insurance. Aims and objectives To determine costs and resource utilization associated with asthma and to analyze the impact of disease severity on subgroups based on age and gender. Methods A claims database analysis from the statutory health insurance perspective was conducted. Patients with an ICD-10-GM code of asthma were extracted from a 10 % sample of a large German sickness fund. Five controls for each asthma patient matched by age and gender were randomly selected from the same database. Costs and resource utilization were calculated for each individual in the asthma and control group. Incremental asthma-related costs were calculated as the mean cost difference. Based on prescribed asthma medication, patients were classified as intermittent or persistent. In addition, age groups of B5, 6-18, and >18 years were analyzed separately and gender differences were investigated. Results Overall, 49,668 individuals were included in the asthma group. On average, total annual costs per patient were (sic)753 higher (p = 0.000)compared to the control group ((sic)2,168 vs. (sic)1,415). Asthma patients had significantly higher (p = 0.000)outpatient ((sic)217), inpatient ((sic)176), and pharmacy costs ((sic)259). Incremental asthma-related total costs were higher for patients with persistent asthma compared to patients with intermittent asthma ((sic)1,091 vs. (sic)408). Women aged[18 years with persistent asthma had the highest difference in costs compared to their controls ((sic.)1,207; p < 0.0001). Corresponding healthcare resource utilization was significantly higher in the asthma group (p = 0.000). Conclusions The treatment of asthma is associated with an increased level of healthcare resource utilization and significantly higher healthcare costs. Asthma imposes a substantial economic burden on sickness funds.
Erscheinungsjahr
Zeitschriftentitel
EUROPEAN JOURNAL OF HEALTH ECONOMICS
Band
17
Ausgabe
2
Seite(n)
195-201
ISSN
eISSN
PUB-ID

Zitieren

Jacob C, Bechtel B, Engel S, et al. Healthcare costs and resource utilization of asthma in Germany: a claims data analysis. EUROPEAN JOURNAL OF HEALTH ECONOMICS. 2016;17(2):195-201.
Jacob, C., Bechtel, B., Engel, S., Kardos, P., Linder, R., Braun, S., & Greiner, W. (2016). Healthcare costs and resource utilization of asthma in Germany: a claims data analysis. EUROPEAN JOURNAL OF HEALTH ECONOMICS, 17(2), 195-201. doi:10.1007/s10198-015-0671-3
Jacob, C., Bechtel, B., Engel, S., Kardos, P., Linder, R., Braun, S., and Greiner, W. (2016). Healthcare costs and resource utilization of asthma in Germany: a claims data analysis. EUROPEAN JOURNAL OF HEALTH ECONOMICS 17, 195-201.
Jacob, C., et al., 2016. Healthcare costs and resource utilization of asthma in Germany: a claims data analysis. EUROPEAN JOURNAL OF HEALTH ECONOMICS, 17(2), p 195-201.
C. Jacob, et al., “Healthcare costs and resource utilization of asthma in Germany: a claims data analysis”, EUROPEAN JOURNAL OF HEALTH ECONOMICS, vol. 17, 2016, pp. 195-201.
Jacob, C., Bechtel, B., Engel, S., Kardos, P., Linder, R., Braun, S., Greiner, W.: Healthcare costs and resource utilization of asthma in Germany: a claims data analysis. EUROPEAN JOURNAL OF HEALTH ECONOMICS. 17, 195-201 (2016).
Jacob, Christian, Bechtel, Benno, Engel, Susanne, Kardos, Peter, Linder, Roland, Braun, Sebastian, and Greiner, Wolfgang. “Healthcare costs and resource utilization of asthma in Germany: a claims data analysis”. EUROPEAN JOURNAL OF HEALTH ECONOMICS 17.2 (2016): 195-201.

6 Zitationen in Europe PMC

Daten bereitgestellt von Europe PubMed Central.

Assessing asthma severity based on claims data: a systematic review.
Jacob C, Haas JS, Bechtel B, Kardos P, Braun S., Eur J Health Econ 18(2), 2017
PMID: 26931557
Budesonide + formoterol delivered via Spiromax® for the management of asthma and COPD: The potential impact on unscheduled healthcare costs of improving inhalation technique compared with Turbuhaler®.
Lewis A, Torvinen S, Dekhuijzen PNR, Chrystyn H, Melani A, Zöllner Y, Kolbe K, Watson AT, Blackney M, Plich A., Respir Med 129(), 2017
PMID: 28732829
Using medication utilization information to develop an asthma severity classification model.
Yu TH, Fu PK, Tung YC., BMC Med Inform Decis Mak 17(1), 2017
PMID: 29262809

26 References

Daten bereitgestellt von Europe PubMed Central.

[Allergic diseases. Results from the German Health Interview and Examination Survey for Children and Adolescents (KiGGS)].
Schlaud M, Atzpodien K, Thierfelder W., Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 50(5-6), 2007
PMID: 17514454
Asthma: prevalence and cost of illness.
Stock S, Redaelli M, Luengen M, Wendland G, Civello D, Lauterbach KW., Eur. Respir. J. 25(1), 2005
PMID: 15640322
Prevalence of asthma and atopy in two areas of West and East Germany.
von Mutius E, Martinez FD, Fritzsch C, Nicolai T, Roell G, Thiemann HH., Am. J. Respir. Crit. Care Med. 149(2 Pt 1), 1994
PMID: 8306030
[Bronchial asthma--a cost of illness analysis]
Nowak D, Volmer T, Wettengel R., Pneumologie 50(5), 1996
PMID: 8710820
Trends in prevalence of atopic diseases and allergic sensitization in children in Eastern Germany.
Heinrich J, Hoelscher B, Frye C, Meyer I, Wjst M, Wichmann HE., Eur. Respir. J. 19(6), 2002
PMID: 12108854

AUTHOR UNKNOWN, 2012
[Guidelines for diagnosis and treatment of asthma patients]
Buhl R, Berdel D, Criee CP, Gillissen A, Kardos P, Kroegel C, Leupold W, Lindemann H, Magnussen H, Nowak D, Pfeiffer-Kascha D, Rabe K, Rolke M, Schultze-Werninghaus G, Sitter H, Ukena D, Vogelmeier C, Welte T, Wettengel R, Worth H., Pneumologie 60(3), 2006
PMID: 16541344

AUTHOR UNKNOWN, 0
[Epidemiology and costs of bronchial asthma and chronic bronchitis in Germany]
Weissflog D, Matthys H, Virchow JC Jr., Dtsch. Med. Wochenschr. 126(28-29), 2001
PMID: 11499261
Medizinische Ökonomie, Kosten der Asthmatherapie nach Schweregrad, Eine empirische Untersuchung
von J-M, Greiner W, Molitor S, Kielhorn A., 1996

AUTHOR UNKNOWN, 0
Cost of illness of atopic asthma and seasonal allergic rhinitis in Germany: 1-yr retrospective study.
Schramm B, Ehlken B, Smala A, Quednau K, Berger K, Nowak D., Eur. Respir. J. 21(1), 2003
PMID: 12570119
The costs of atopy and asthma in children: assessment of direct costs and their determinants in a birth cohort.
Weinmann S, Kamtsiuris P, Henke KD, Wickman M, Jenner A, Wahn U., Pediatr Allergy Immunol 14(1), 2003
PMID: 12603707
Krankheitskosten-Studie und Kosten-Nutzen-Analyse der spezifischen Immuntherapie bei Asthma
Märtens P, Lobermeyer K., 2001
[Costs of illness for asthma and COPD in adults in Germany].
Kirsch F, Teuner CM, Menn P, Leidl R., Gesundheitswesen 75(7), 2013
PMID: 23553190
[Recommendations of the German Respiratory Tract League on asthma management of adults and children. The German Respiratory Tract League]
Wettengel R, Berdel D, Cegla U, Fabel H, Geisler L, Hofmann D, Krause J, Kroidl RF, Lanser K, Leupold W., Med. Klin. (Munich) 89(2), 1994
PMID: 7909352
[Epidemiology and costs of asthma in Germany - a systematic literature review].
Aumann I, Prenzler A, Welte T, Gillissen A., Pneumologie 68(8), 2014
PMID: 25003905

AUTHOR UNKNOWN, 0

AUTHOR UNKNOWN, 0
Bewertung von Ressourcen im Gesundheitswesen aus der Perspektive der deutschen Sozialversicherung
Prenzler A, Zeidler J, Braun S, von JM., 2010

AUTHOR UNKNOWN, 0
[Health services research based on routine data generated by the SHI. Potential uses of health insurance fund data in health services research].
Schubert I, Koster I, Kupper-Nybelen J, Ihle P., Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 51(10), 2008
PMID: 18985403
[Methods of health economic evaluation for health services research].
Icks A, Chernyak N, Bestehorn K, Bruggenjurgen B, Bruns J, Damm O, Dintsios CM, Dreinhofer K, Gandjour A, Gerber A, Greiner W, Hermanek P, Hessel F, Heymann R, Huppertz E, Jacke C, Kachele H, Kilian R, Klingenberger D, Kolominsky-Rabas P, Kramer H, Krauth C, Lungen M, Neumann T, Porzsolt F, Prenzler A, Pueschner F, Riedel R, Ruther A, Salize HJ, Scharnetzky E, Schwerd W, Selbmann HK, Siebert H, Stengel D, Stock S, Voller H, Wasem J, Schrappe M., Gesundheitswesen 72(12), 2010
PMID: 20865653
Gesundheitsbezogene Versorgungsforschung mit GKV-Routinedaten—Grenzen am Beispiel der Prophylaxe venöser Thromboembolien in der Hüft- und Kniegelenkendoprothetik
Bowles D, Damm O, Greiner W., 2011
[Appraisal of resource use in the German health-care system from the perspective of the statutory health insurance].
Braun S, Prenzler A, Mittendorf T, von der Schulenburg JM., Gesundheitswesen 71(1), 2009
PMID: 19173145

Export

Markieren/ Markierung löschen
Markierte Publikationen

Open Data PUB

Web of Science

Dieser Datensatz im Web of Science®

Quellen

PMID: 25716136
PubMed | Europe PMC

Suchen in

Google Scholar